Alibaba Health Informatio... (ALBHF)
OTC: ALBHF
· Real-Time Price · USD
0.67
0.01 (1.89%)
At close: Aug 15, 2025, 9:30 AM
0.66
-1.79%
After-hours: Aug 13, 2025, 08:00 PM EDT
Alibaba Health Information Technology Income Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
Revenue | 30.6B | 36.51B | 35.38B | 41.2B | 49.32B | 46.75B | 39.72B | 37.98B | 32.08B | 28.93B | 24.88B | 21B | 16.76B |
Cost of Revenue | 23.17B | 28B | 27.31B | 32.02B | 38.51B | 36.67B | 31.15B | 30.04B | 25.67B | 23.07B | 19.39B | 16.19B | 12.68B |
Gross Profit | 7.43B | 8.51B | 8.07B | 9.18B | 10.81B | 10.08B | 8.57B | 7.94B | 6.41B | 5.87B | 5.49B | 4.81B | 4.08B |
Operating Income | 1.48B | 1.51B | 1.35B | 1.22B | 814.52M | 397.85M | 208.57M | -558.83M | -1.14B | -1.28B | -553.63M | -21.49M | 154.69M |
Interest Income | n/a | 294.7M | 294.7M | 496.56M | 679.17M | 527.61M | 527.61M | 446.05M | 352.9M | 311.73M | 253.8M | 203.32M | 104.15M |
Pretax Income | 1.56B | 1.65B | 1.51B | 1.58B | 1.55B | 1.26B | 1.03B | 528.34M | -78.54M | -175.74M | 171.36M | 404.69M | 333.54M |
Net Income | 1.43B | 1.54B | 1.43B | 1.49B | 1.48B | 1.2B | 981.54M | 501.87M | -103.36M | -200.4M | 116.82M | 343.1M | 276.85M |
Selling & General & Admin | 5.23B | 6.09B | 5.82B | 6.9B | 8.73B | 8.47B | 7.34B | 7.39B | 6.48B | 6.21B | 5.27B | 4.27B | 3.44B |
Research & Development | 720.05M | 905.71M | 898.32M | 1.06B | 1.25B | 1.19B | 997.14M | 1.08B | 1.05B | 923.01M | 746.38M | 541.34M | 482.29M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.95B | 7B | 6.72B | 7.94B | 9.77B | 9.39B | 8.07B | 7.86B | 6.84B | 6.36B | 5.57B | 4.61B | 3.85B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.26B | 2.53B | 2.34B | 2.72B | 3.14B | 3.09B | 2.64B | 2.77B | 2.84B | 2.69B | 2.21B | 1.61B | 1.23B |
Cost & Expenses | 29.12B | 35B | 34.03B | 39.96B | 48.28B | 46.06B | 39.21B | 37.9B | 32.51B | 29.42B | 24.96B | 20.8B | 16.52B |
Income Tax Expense | 127.95M | 110.12M | 82.22M | 92.34M | 70.35M | 60.68M | 50.61M | 26.21M | 23.89M | 26.08M | 60.24M | 70.07M | 70.68M |
Shares Outstanding (Basic) | 16.18B | 16.18B | 16.09B | 16.09B | 14.63B | 14.63B | 13.55B | 13.54B | 13.52B | 13.49B | 13.48B | 13.45B | 13.12B |
Shares Outstanding (Diluted) | 16.18B | 16.18B | 16.1B | 16.1B | 14.63B | 14.63B | 13.55B | 13.56B | 13.52B | 13.49B | 13.48B | 13.53B | 13.12B |
EPS (Basic) | 0.09 | 0.10 | 0.09 | 0.10 | 0.11 | 0.09 | 0.07 | 0.04 | -0.01 | -0.01 | 0.01 | 0.03 | 0.02 |
EPS (Diluted) | 0.09 | 0.10 | 0.09 | 0.10 | 0.11 | 0.09 | 0.07 | 0.04 | -0.01 | -0.01 | 0.01 | 0.03 | 0.02 |
EBITDA | 1.49B | 1.52B | 1.37B | 1.25B | 853.93M | 440.99M | 247.72M | -515.44M | -1.1B | -1.25B | -533.45M | 4.15M | 174.73M |
EBIT | 1.45B | 1.49B | 1.34B | 1.21B | 811.36M | 395.96M | 208.57M | -558.83M | -1.14B | -1.28B | -553.63M | -21.49M | 154.69M |
Depreciation & Amortization | 32.13M | 34.46M | 30.91M | 36.4M | 42.57M | 45.03M | 39.15M | 43.39M | 36.11M | 30.9M | 20.19M | 25.64M | 20.04M |